FDA Approves Udenyca (pegfilgrastim-cbqv), a Biosimilar to Neulasta

REDWOOD CITY, Calif., Nov. 02, 2018 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (NASDAQ: CHRS), today announced that the U.S. Food and Drug Administration (FDA) has approved Udenyca (pegfilgrastim-cbqv), the first pegfilgrastim biosimilar approved...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news